Short radiation schedule after lumpectomy for early breast cancer
Part of Cancer, Skin clinical trials.
This trial tests whether a shorter course of radiation therapy (called hypofractionated) after lumpectomy is safe and works well for early breast cancer. It aims to make treatment more convenient while keeping the same benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally able to take care of yourself (ECOG score 0 to 2).
- You have been diagnosed with early breast cancer (invasive or ductal carcinoma in situ).
- Your cancer is early stage (no lymph node involvement or spread).
- You had breast-conserving surgery (lumpectomy).
- The surgeon removed the cancer with a clear margin (>2 mm).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This study compares a shorter course of radiation to a standard longer course after breast-conserving surgery (lumpectomy). It’s meant to see which schedule works just as well while focusing on safety and cancer control.
This trial tests a shorter course of radiation therapy (called extreme hypofractionation) after surgery for early-stage breast cancer. It aims to see if fewer, higher-dose radiation sessions are as effective and safe as standard radiation, potentially reducing treatment time.
Hear when a new Early Stage Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.